Related Experiment Video
Updated: May 12, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
[Clinical guidelines for hepatitis B virus infection in kidney transplant recipients (2023 edition)]
Insights
Hepatitis B virus (HBV) poses risks for kidney transplant patients due to immunosuppression. This guideline standardizes diagnosis and treatment for HBV infection in these vulnerable individuals.
Area of Science:
- Nephrology
- Hepatology
- Infectious Diseases
Abstract:
The hepatitis B virus (HBV) is a liver-loving, double-stranded, circular DNA virus. The prevalence of hepatits B surface antigen(HBsAg)in the general population of China is approximately 6.1%, indicating a large base of HBV-infected individuals. The infection rate of HBV in the blood dialysis patient population is significantly higher than that in the general population. Kidney transplant recipients, being in an immunosuppressed state, are susceptible to HBV infection, and previous HBV infections may reactivate, affecting the long-term survival of the recipient and the transplanted kidney. To further standardize the diagnosis and treatment of HBV infection after kidney transplantation, the Transplantation Branch of the Chinese Medical Association has organized domestic experts to develop this guideline from aspects such as epidemiology, routes of HBV infection in kidney transplant recipients, indications for kidney transplantation in HBV-infected individuals, and the diagnosis, prevention, and treatment of HBV infection in kidney transplant recipients, in order to help kidney transplant professionals standardize and optimize the management of HBV infection.
Related Concept Videos
Myocarditis III: Medical Management
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Cytomegalovirus Disease
Hepatitis
Viral Hepatitis I: Introduction

